General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(SIGNIFICANT), Kowa(SIGNIFICANT), Esperion(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Amgen(SIGNIFICANT)

View Full Disclosure